Ads
related to: regenerative medicine
Search results
Meso Numismatics Updates Progress on Strategic Expansion Into the UAE With ReGen Dubai
NewMediaWire via Yahoo Finance· 3 days agoLAS VEGAS, NV - (NewMediaWire) - June 03, 2024 - Meso Numismatics, Inc. ("Meso Numismatics" or the...
Tempo Therapeutics Announces Appointment of Eric I. Richman to Board of Directors
Tehachapi News· 13 hours agoTempo Therapeutics, Inc. ("Tempo"), a leading innovator in tissue engineering and regenerative medicine, today announced the addition of Eric I. Richman ...
Best Glucose Monitors | Fortune Recommends Health
Fortune· 6 days agoWe conducted thorough research on numerous glucose monitoring devices and services, analyzing accuracy, cost, and insurance coverage. Additionally, we...
FDA grants RMAT status for BlueRock’s Parkinson’s therapy
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US Food and Drug Administration (FDA) has granted a regenerative medicine advanced therapy...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 3 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Most stem cells die after being injected into the brain. This new technique could change that
Medical Xpress· 2 hours agoWhen the myelin sheath that surrounds nerve fibers in the brain and spinal cord becomes damaged, a...
spacetoday.net: older news articles
Spacetoday.net· 1 hour ago...nearby star's relentless radiation Johns Hopkins University 5:14 am ET (0914 GMT) Trailblazers to Lead ISSRDC Panel on Cancer Research, Regenerative Medicine, and In-Space Manufacturing CASIS 5:14 am ET (0914 GMT) China’s Chang’e-6 snagged the first samples from the farside of the moon...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoLongeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic ...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 1 day ago/II GARDian study on OCU410ST for the treatment of Stargardt disease. An update on the clinical...
Humacyte CEO Niklason buys $15k in company stock By Investing.com
Investing.com· 3 days agoNiklason purchased shares worth approximately $15,000. The transaction, dated June 3, 2024, involved...